{"filing":{"accession_number":"0001213900-26-072033","cik":"0001840877","ticker":"COCHW","company_name":"Envoy Medical, Inc.","form":"8-K","filing_date":"2026-06-25","report_date":null,"primary_document":"ea0295990-8k_envoy.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1840877/000121390026072033/ea0295990-8k_envoy.htm"},"events":[{"id":13849,"run_id":12303,"accession_number":"0001213900-26-072033","anchor_item_number":"5.02","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"The Compensation Committee approved material changes to CEO Brent Lucas's compensation package, including an updated base salary of $420,000, a targeted cash bonus of $105,000, and equity grants of 1,000,000 stock options and 1,000,000 RSUs with performance-based vesting tied to FDA approval of the Acclaim cochlear implant. This is a compensatory arrangement disclosure under Item 5.02(e), distinct from an appointment or departure.","company_name":"Envoy Medical, Inc.","ticker":"COCHW","filing_date":"2026-06-25","form":"8-K","submitted_at":null,"items":[{"id":11112,"accession_number":"0001213900-26-072033","item_number":"5.02","item_title":"Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The Compensation Committee approved material changes to CEO Brent Lucas's compensation package, including an updated base salary of $420,000, a targeted cash bonus of $105,000, and equity grants of 1,000,000 stock options and 1,000,000 RSUs with performance-based vesting tied to FDA approval of the Acclaim cochlear implant. This is a compensatory arrangement disclosure under Item 5.02(e), distinct from an appointment or departure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-25T20:02:54.555824+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":11112,"accession_number":"0001213900-26-072033","item_number":"5.02","item_title":"Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers","event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"The Compensation Committee approved material changes to CEO Brent Lucas's compensation package, including an updated base salary of $420,000, a targeted cash bonus of $105,000, and equity grants of 1,000,000 stock options and 1,000,000 RSUs with performance-based vesting tied to FDA approval of the Acclaim cochlear implant. This is a compensatory arrangement disclosure under Item 5.02(e), distinct from an appointment or departure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-25T20:02:54.555824+00:00","company_name":"Envoy Medical, Inc.","ticker":"COCHW","filing_date":"2026-06-25"}]}